Defective Consumer Product Claims in Ireland: Personal Injury and Medical Negligence (2026 Guide)

Key facts at a glance

A snapshot of the legal framework, deadlines, and procedure for a defective consumer product injury claim in Ireland.

Strict liability:

section 2, Liability for Defective Products Act 1991

Time limit:

three years (section 7(1))

Longstop:

ten years from market placement (section 7(2))

Producer's defences:

six, under section 6

Joint and several:

section 8 + Civil Liability Act 1961, section 21

IRB application:

mandatory before court, PIAB Act 2003 section 12 (operating via section 11 application)

Med-neg carve-out:

PIAB Act 2003, section 3

Authorisation:

PIAB Act 2003, section 50

Respondent consent window:

90 days

Claimant accept-or-reject:

28 days

IRB application fee:

€45 online, €90 by post

IRB resolution time:

2.7 years average (IRB AR 2024)

Litigated claim:

5.1 years average (Central Bank NCID)

Average legal fees:

€694 IRB vs €25,055 court

Quantum framework:

Personal Injuries Guidelines 2021 (1st ed)

Forward law:

Directive (EU) 2024/2853, transposed by 9 December 2026 [3]

What should you do in the first 48 hours after a defective product injury?

To protect a defective consumer product injury claim in Ireland, take five practical steps before you contact anyone else. Each one preserves a piece of evidence that the IRB and any later court will look for.

1. Keep the product itself. Do not discard it, return it for a refund, or accept a replacement until your solicitor has seen it. The physical product is often the single most important piece of evidence in a strict-liability claim.
2. Photograph the injury, the product, and the scene. Take dated photographs from several angles. Capture serial numbers, batch codes, and any visible defect or burn pattern.
3. See your GP within 48 hours. Contemporaneous medical records anchor the link between the defect and the injury. The IRB requires a Form B medical report later, and that report builds on what your GP recorded at the time.
4. Find the receipt, packaging, instruction manual, and any safety leaflet. The instructions and warnings are often what makes a product defective or what defeats a "misuse" defence later.
5. Contact a solicitor before signing anything. Insurers and manufacturers sometimes approach injured consumers with early settlement offers. A letter of claim under section 8 of the Civil Liability and Courts Act 2004 protects your position while the strict-liability case is being prepared.

In our experience handling defective consumer product cases, the single most common mistake is returning the product for a refund the next day. The retailer disposes of it, and the strongest piece of evidence is gone before anyone has even looked at it.

How do you make a defective product claim in Ireland?

To make a defective consumer product injury claim in Ireland, you take six steps in order. Secure the product as evidence, see your GP, instruct a solicitor, file IRB Form A, submit Form B, and either accept the IRB assessment or proceed to the High Court on a section 50 Authorisation.

1. Secure the product as evidence. Keep the product, its packaging, the receipt, and any warning labels. Do not return it for a refund.
2. See your GP within 48 hours. An early medical record connects the injury to the defective product and protects causation later.
3. Instruct a solicitor. A consultation under section 150 of the Legal Services Regulation Act 2015 sets out fees in writing before you sign anything. Most defective product claims are run on a no-win-no-fee basis.
4. File Form A with the Injuries Resolution Board. The €45 online application at injuries.ie stops the three-year limitation clock running under section 50 of the PIAB Act 2003 [4].
5. Submit Form B. Form B is a structured medical report from your treating doctor. It must address history, examination, treatment, prognosis, and the causal link between the defect and the injury.
6. Wait for the IRB assessment, then decide. If the producer consents within 90 days, the Board issues a written assessment. If you and the producer accept, the Board issues an Order to Pay. If either side rejects, the Board issues a section 50 Authorisation and your solicitor can issue High Court proceedings within six months.

The whole process usually takes 11 months at the IRB stage [2]. If court proceedings are needed, the average total time is 5 years against 2.7 years for IRB-resolved claims [8]. Do not delay starting Step 4: filing Form A is the only act that stops the limitation clock.

What counts as a defective consumer product in Ireland?

A defective consumer product in Ireland is one that does not provide the safety a person is entitled to expect, taking all the circumstances into account, under section 5 of the Liability for Defective Products Act 1991 [1]. Safety here means safety from physical injury, not whether the product works as advertised. A toaster that simply does not toast is faulty. A toaster that bursts into flames is defective.

The 1991 Act treats a "product" as any movable item, including components, electricity, and items used to make other items. Software and pure digital files are not yet "products" under Irish law, although that changes when the EU 2024 Directive arrives in December 2026 (see what changes on 9 December 2026).

The three categories of defect

Solicitors and courts group defects into three categories. The legal route is the same for all three, although the evidence differs.

Refunds and injury claims are separate. Many people take a refund under the Consumer Rights Act 2022 and assume the injury claim is gone with it. It is not. A refund settles the contract claim against the retailer. The strict-liability injury claim against the producer under the 1991 Act survives that refund.

The two regimes operate on different parties, different timelines, and different remedies. The Consumer Rights Act 2022 sits between consumer and retailer and remedies failures to deliver goods of merchantable quality (refund, repair, replacement). The 1991 Act sits between any injured person and the producer of a defective product, and remedies physical injury and consequential loss. Section 11 of the 1991 Act expressly preserves any other rights or remedies the injured person has, so the two routes are cumulative, not alternative. A consumer who has accepted a refund retains the strict-liability claim. A consumer who declines a refund and proceeds with the injury claim does not lose either. The retailer in the contract route may not even be a defendant in the injury route, because the 1991 Act runs to the producer first.

Who can you sue under the producer chain in Ireland?

Strict liability under section 2 of the 1991 Act means that you do not have to prove the producer was negligent. You do still have to prove there was a defect, that the product caused your injury, and the extent of your loss, on the balance of probabilities. Section 4 places that proof on the injured party.

The three elements section 4 requires are distinct.

• Defect is proved by reference to the section 5 test (the product did not provide the safety a person was entitled to expect), typically supported by a forensic engineering report or by the recall notice itself.
• Damage is proved by medical evidence (Form B for the IRB stage, more detailed reports later if proceedings issue).
• Causation is the bridge between the two and is often where strict-liability claims are contested in court, because the producer can concede defect and damage in principle but argue the defect was not the actual cause of the injury.

Each element is proved separately, on the balance of probabilities (more likely than not), not the criminal "beyond reasonable doubt" standard.

Unlike under the UK Consumer Protection Act 1987, in Ireland section 2 of the Liability for Defective Products Act 1991 places liability primarily on the producer. Importers and own-branders are treated as producers when goods are placed on the EU market or rebadged. The retailer is only a fallback defendant if the producer cannot be identified.

The producer chain runs in five stages. First, the manufacturer of the finished product. Second, the producer of any defective component. Third, an "own-brander" who puts their name on the product. Fourth, the importer who brings it into the EU. Finally, the retailer or supplier as a last resort. Where two or more contributed to the defect, section 8 makes them jointly and severally liable.

A worked example shows the practical effect. Suppose a defective hand-held power tool injures the user because the trigger lock was poorly designed (manufacturer's design defect) and the lithium battery cell that powered it was contaminated during assembly (component manufacturer's defect). Under section 8, the injured user can sue the finished-product manufacturer for the entire loss, or sue the battery-cell producer for the entire loss, or sue both. The defendants then sort out contribution among themselves under section 21 of the Civil Liability Act 1961 [13], which apportions liability between concurrent wrongdoers in the proportion the court considers just having regard to the degree of fault [11]. The injured user does not have to allocate fault between the two defendants and does not lose if one defendant is insolvent.

What if the manufacturer is overseas?

If the producer is outside the EU, the importer who brought the product into the EU is treated as the producer for liability purposes. You do not need to chase the foreign manufacturer through their home courts. You sue the EU importer here.

This leads to the question of timing. The producer chain only matters if the claim is filed within the time limits set by section 7 of the Liability for Defective Products Act 1991 [1].

How long do you have to claim a defective product injury in Ireland?

You have three years from the date the damage was caused, or from the date you first became aware (or should reasonably have become aware) of the damage, the defect, and the producer's identity. This rule appears in section 7(1) of the 1991 Act [1]. There is also an absolute ten-year longstop in section 7(2) [1], running from the date the producer placed that specific product into circulation.

This three-year rule is the most-misstated fact about defective product law in Ireland. The general personal-injury limitation period under section 7 of the Civil Liability and Courts Act 2004 is two years. The 1991 Act overrides that two-year rule for strict-liability defective product claims and gives you a year longer.

What if the injury appeared years later?

The "date of knowledge" rule means the three-year clock starts when you first knew, or should reasonably have known, three things: that you had been injured, that the product was defective, and who the producer was. For latent injuries, that may be years after the product was first used. The ten-year longstop in section 7(2) still applies, however, and that is an absolute outer boundary the date-of-knowledge rule cannot extend. The same date-of-knowledge concept runs through limitation periods for personal injury claims in Ireland generally. The new EU 2024 Directive proposes a 25-year longstop for slow-emerging injuries from products placed on the market after transposition (see what changes on 9 December 2026).

How does the Injuries Resolution Board handle a defective product claim?

The IRB process for a defective consumer product injury claim runs in eight stages, from filing Form A through to either an assessment or a section 50 Authorisation to issue court proceedings. Most consumer-product injury cases must go through this process before any High Court proceedings can begin. Section 12 of the Personal Injuries Assessment Board Act 2003 [4] bars personal injury proceedings unless an application has first been made to the IRB under section 11. An authorisation must then issue under section 14, 17, 32 or 36 before proceedings can be brought.

Unlike in England and Wales where there is no equivalent assessment body, in Ireland the Injuries Resolution Board (IRB), formerly known as PIAB until 2023, acts as a mandatory assessment stage for product-liability injury claims.

1. File Form A and pay the fee. The application is made online at injuries.ie with a €45 fee, or by post with a €90 fee [2]. Filing stops the three-year limitation clock.
2. Submit Form B. Form B is the structured medical report from your treating doctor. The IRB tightened its validation rules in September 2023, so a few photocopied GP notes are no longer enough.
3. The IRB notifies the producer. The Board writes formally to the producer (and any importer or own-brander you have named).
4. The producer has 90 days to consent. If the producer agrees, the process continues. If the producer refuses (silence counts as refusal), the IRB issues an Authorisation under section 50 of the PIAB Act 2003.
5. Independent medical assessment. The IRB instructs an independent medical examiner to assess your injuries against the Personal Injuries Guidelines [7].
6. The IRB issues a written assessment. The Board values general damages and special damages and writes to both sides with the figure.
7. You have 28 days to accept or reject. If you accept and the producer accepts, the IRB issues an Order to Pay enforceable as a court judgment. If either side rejects, the IRB issues an Authorisation.
8. Order to Pay or section 50 Authorisation. The Authorisation is your solicitor's permission to issue High Court proceedings at the Four Courts in Dublin. Without it, the proceedings would be struck out.

What if the manufacturer refuses to consent? Section 50 Authorisation

The IRB issues a section 50 Authorisation [4] when the producer declines to participate or when the Board determines the claim is unsuitable for assessment. This Authorisation is what your solicitor needs to start proceedings in the High Court at the Four Courts. In our experience handling defective product cases against multinational manufacturers, the consent rate is materially lower than in motor liability claims. A section 50 Authorisation is a normal outcome here, not a setback.

The Authorisation has a fuse on it. Under the case law applying section 50 read with the Statute of Limitations, the proceedings must be issued in court within a set period after the Authorisation date. The general rule is that limitation continues to be paused for six months after the Authorisation issues, then runs again. In practice, this means a claimant who receives an Authorisation should not delay: late issue can re-open a limitation argument that was previously stopped by the IRB application. The longer of the original section 7(1) three-year limit and the post-Authorisation pause is what governs, but assuming the original three years are close to running, the Authorisation creates effective urgency.

Form A and Form B: what changed in September 2023

The most common procedural delay we see in defective product cases is securing a properly structured Form B. Since the IRB's September 2023 changes, applications relying on raw GP printouts have been rejected. Form B has to be a structured report by a registered doctor that addresses injury, treatment, prognosis, and causation. The doctor completing Form B should be familiar with the IRB's requirements.

In practice, a compliant Form B for a defective consumer product injury claim addresses six headings:

• History: the mechanism of injury and what the product was doing when it failed.
• Examination findings: the doctor's clinical findings at first presentation.
• Investigations: X-rays, scans, blood work, and their results.
• Treatment provided: acute and ongoing care.
• Prognosis: expected recovery timeline and any permanent effects.
• Causation opinion: linking the injury to the product defect rather than to a pre-existing condition.

The IRB will return Form B applications that omit the causation opinion. A general practitioner unfamiliar with the post-2023 template often produces a clinically accurate but procedurally non-compliant report.

When does a defective medical device claim cross into medical negligence?

The line between a defective medical device claim and a medical negligence claim is the difference between suing the manufacturer for a product fault and suing the surgeon or hospital for clinical negligence. Where both apply, both claims can be pleaded together, although the procedural routes are not the same.

Under section 3 of the PIAB Act 2003, the IRB cannot assess medical negligence claims. Those go directly to court. Medical negligence claims against a clinician or hospital must be issued in the Circuit Court (up to €75,000) or the High Court at the Four Courts in Dublin. A defective medical device claim against the manufacturer, by contrast, is a strict-liability claim under the 1991 Act and goes through the IRB first, exactly like any other consumer product claim.

Where a defective medical device fails after a flawless surgical implantation, the strict-liability route under the 1991 Act runs against the manufacturer through the IRB. Where the surgery itself was performed below the Dunne standard, the medical-negligence route runs directly to the Circuit or High Court because the IRB cannot assess medical negligence. Where both go wrong (the device is defective and the surgeon should have spotted a recall notice), the two routes are pleaded together. Cases like the DePuy ASR hip-implant litigation typically pleaded both, partly to prevent each defendant from blaming the other.

A practical point: the IRB application stops the limitation clock for the manufacturer claim, but it does not stop the clock for any negligence claim against the surgeon or hospital. Where both are in play, both have to be issued separately, in time.

What evidence should you gather after a defective product injury?

Strong defective product evidence is physical, contemporaneous, and tied directly to the defect that caused the injury. Without it, even a clear-on-paper strict-liability claim can collapse on causation. The evidence checklist below is what we ask clients to assemble before the first consultation.

1. The product itself, kept in the condition it was in immediately after the incident.
2. Photographs of the injury, the product, the scene, and any visible defect, burn pattern, or fracture.
3. Receipts, packaging, instruction manuals, warranty cards, and any safety leaflet that came with the product.
4. Medical records from your GP, A&E attendance, hospital discharge letter, and any specialist reports.
5. Witness names and contact details, including anyone who saw the incident or experienced the same product fault.
6. Any safety notice, recall notice, or correspondence from the producer or retailer.

A safety recall by the Competition and Consumer Protection Commission [5] or by the Health Products Regulatory Authority [6] is not a finding of liability, although it is strong supporting evidence. A recall confirms the regulator has accepted, on the producer's own data or after testing, that the product is unsafe. It does not, on its own, prove the recalled defect caused your specific injury, so the medical and product-engineering evidence still has to bridge that gap.

At this point, you will need to decide what your claim is worth in compensation terms, which is governed by the Personal Injuries Guidelines 2021.

How much compensation can you get for a defective product injury in Ireland?

Compensation in a defective consumer product injury claim is calculated under the Personal Injuries Guidelines 2021, which the IRB and the courts apply to all personal injury awards in Ireland. Awards vary case by case.

Specific awards depend on medical evidence, recovery prognosis, and circumstances. The Guidelines are reference bands, not formulas. A solicitor must value any individual case.

The Personal Injuries Guidelines 2021 [7] (1st edition) remain in force in May 2026. The Personal Injuries Guidelines Committee, established under section 18 of the Judicial Council Act 2019 [12], must review the Guidelines at least every three years. The first such review concluded in March 2024 and the Judicial Council adopted draft amendments proposing an across-the-board 16.7% uplift in February 2025. In July 2025, the Minister for Justice confirmed he would not bring a resolution to the Oireachtas seeking approval of the draft, and the draft was laid before the Oireachtas in September 2025 without any approval resolution [7]. The Supreme Court in Delaney v Personal Injuries Assessment Board [2024] IESC 10 held section 7(2)(g) of the Judicial Council Act 2019 unconstitutional, so any future amendments now require explicit Oireachtas approval. Under the Government's Action Plan for Insurance Reform 2025-2029 [15], the Judicial Council (Amendment) Bill 2026 entered pre-legislative scrutiny in February 2026 to reform the review and approval process. Until any revised Guidelines are approved, the 2021 1st edition figures govern every IRB assessment and court award, including for defective consumer product injury claims.

Compensation has two parts. General damages are for pain, suffering, and loss of amenity. Special damages are for actual financial loss: medical bills, lost earnings, replacement equipment, future care.

What the IRB process delivers in product cases: what to expect

The IRB's 2024 Annual Report shows 20,837 claims received, a 70% respondent-consent rate across the system, an 11.2-month average assessment timeline, and €168 million in awards [2]. From handling defective consumer product cases in Irish practice, two qualifications matter for product-liability readers in particular.

First, the average IRB-assessed claim resolves in 2.7 years against 5.1 years for litigated claims, a 47% time advantage on Central Bank data [8]. The consent rate in product-liability cases is materially lower than in motor liability, however, so a section 50 Authorisation is a more common outcome here. Second, the average legal cost of an IRB-resolved claim is €694, against €25,055 for a litigated claim, on the Central Bank's National Claims Information Database [8]. The cost gap is the strongest argument for engaging fully with the IRB stage even when court proceedings look likely.

A note on early settlement offers. Insurers and self-insured manufacturers sometimes approach injured consumers with quick offers before the Form B medical report is finalised. Central Bank analysis has shown that claimants who proceed through the IRB process to assessment often receive higher figures than those who take the early offer. You should not sign anything without a solicitor reviewing the offer against the Personal Injuries Guidelines 2021. The next step is to gather the evidence the IRB will weigh, which is the subject of the next section.

What changes on 9 December 2026 under EU Directive 2024/2853?

Irish defective product law changes on 9 December 2026 when Directive (EU) 2024/2853 [3] must be transposed into national law. The Department of Enterprise [9], Tourism and Employment has confirmed the deadline is expected to be met. The new regime applies to products placed on the market after transposition. The 1991 Act keeps governing products already in circulation.

Software, AI, and digital health products as "products" under the new Directive

The biggest expansion is the new Directive's treatment of software, AI systems, and digital health products as "products". Today, an algorithmic error in a smartwatch heart-rate monitor or an AI-based diagnostic tool sits in a grey zone between contract law and professional negligence. After 9 December 2026, those failures fall within the strict-liability regime for products placed on the market after transposition. The Department of Enterprise has indicated implementing legislation will follow the Directive's structure closely [9].

The Directive also expressly recognises psychological injury as a standalone head of damage. Today in Ireland, psychological harm without an associated physical injury is a difficult claim. After transposition, it becomes a clear category. Separately, the Representative Actions for the Protection of the Collective Interests of Consumers Act 2023 commenced on 30 April 2024, opening collective-redress proceedings for the first time in Ireland. The Irish Council for Civil Liberties was designated as the first qualified entity on 5 June 2024. The High Court granted ICCL permission on 26 May 2025 to bring Ireland's first representative action, which was formally launched against Microsoft on 29 May 2025.

When the new presumption of defect applies (Article 9)

The headline change in the 2024 Directive is that the burden of proof shifts in claimant-favourable circumstances. Article 9 of Directive (EU) 2024/2853 [3] sets out the specific triggers for a rebuttable presumption that the product was defective, that the damage was caused by the defect, or both. Three triggers apply. The first is excessive difficulty for the claimant due to the technical or scientific complexity of proving defect or causation. The second is asymmetric information, where the producer holds technical evidence the claimant cannot reasonably access. The third is product non-compliance with mandatory safety requirements under EU or national law. Where any of these fires, the producer must rebut the presumption rather than the claimant having to prove the underlying point. For complex consumer-electronics or medical-device cases this is a fundamental change to the evidence burden.

What defences can a manufacturer raise under section 6?

Section 6 of the 1991 Act gives a producer six statutory defences. Each one is the producer's burden to prove. They do not shift any of the elements you must prove.

• The producer did not put the product into circulation. Useful where a product was counterfeit or stolen before it reached the market.
• The defect did not exist when the product was put into circulation. The producer can argue the defect arose from later misuse or third-party modification.
• The product was not made for sale or any commercial purpose. A narrow defence that almost never applies to goods sold to the public.
• The defect was due to compliance with a mandatory legal requirement. The producer must show the law forced the design choice that caused the defect.
• State of the art (section 6(e)). The development-risks defence: the producer must show scientific and technical knowledge at the time of circulation could not have revealed the defect.
• Component-only liability. A component manufacturer can argue the defect is attributable to the design of the finished product or to the instructions of the finished-product producer.

Contributory negligence: when the claimant is partly at fault

If the producer can show you contributed to your own injury, your award is reduced in proportion under the Civil Liability Act 1961, Part III. Reduction is not extinction. Even where misuse is plainly part of the picture, the strict-liability claim against the producer can still succeed. A common scenario in our practice involves chargers and lithium-ion batteries: the producer often argues the consumer used a non-original charger. Where the warning was unclear, or compatible-looking aftermarket chargers were on sale, the producer's defence is much weaker than a quick reading suggests.

What are the common types of defective consumer product claims?

The most-frequently encountered defective consumer product claims in Ireland fall into a small number of categories, each with its own evidence pattern.

• Household electricals and white goods. Heaters, washing machines, kettles, hair dryers. The CCPC issued an October 2025 alert covering around 114,000 Tucson circulating pumps with electrocution risk in Irish homes [5].
• Lithium-ion batteries and "thermal runaway". E-bikes, e-scooters, power banks, and laptops can fail catastrophically when battery cells are damaged or charged with incompatible chargers. Severe burns and smoke-inhalation injuries are common.
• Toys and children's products. Choking hazards, small magnets, faulty restraints. The CCPC removed more than 25,000 unsafe toys from the Irish market in the year to October 2025.
• Medical devices. Hip implants, pacemakers, insulin pumps, surgical mesh. The HPRA issued a priority-2 warning on the Tandem t:slim X2 insulin pump in December 2025 [6].
• Pharmaceuticals. Contaminated batches, manufacturing errors, inadequate warnings. These claims often proceed alongside medical-negligence claims and increasingly under collective-redress proceedings.
• Food and drink contamination. Foreign bodies, allergen mislabelling, microbial contamination causing illness.

If your injury arose from a workplace tool rather than a household product, see defective workplace equipment. If it arose from a vehicle component, see defective vehicle parts. For severe burns from faulty heating or electrical products, see burns and chemical exposure injury.

Glossary: key terms in a defective consumer product claim

Form A

The Injuries Resolution Board application form. Filing Form A on injuries.ie (€45 online or €90 by post) starts the IRB assessment process and stops the three-year limitation clock running.

Form B

The structured medical report from a registered medical practitioner that the IRB requires alongside Form A. After September 2023, Form B must address history, examination, investigations, treatment, prognosis, and a causation opinion linking the injury to the product defect.

Section 50 Authorisation

A written notice the IRB issues under section 50 of the PIAB Act 2003 when the producer declines to consent to assessment. The Authorisation is what a solicitor needs to issue High Court proceedings.

Producer

Defined in section 2 of the 1991 Act as the manufacturer of a finished product, the producer of a defective component, an "own-brander" who puts their name on a product, or the EU importer. Where none can be identified within a reasonable period, the supplier (retailer) becomes the fallback defendant.

Order to Pay

The IRB's binding award when both sides accept the assessment. Enforceable as if it were a court judgment under the PIAB Act 2003.

Date of knowledge

The point at which the injured person first knew, or ought reasonably to have known, three things: that they had been injured, that a product was defective, and the producer's identity. The three-year limitation period under section 7(1) of the 1991 Act runs from this date.

Frequently asked questions

What to consider next

Three questions naturally follow on from the material above. Each links to a deeper page on the site.

• How does the IRB calculate compensation under the 2021 Guidelines? See our guide to compensation under the Personal Injuries Guidelines 2021.
• What is the difference between a defective consumer product claim and a workplace defective equipment claim? Workplace claims sit under different employer-duty rules. See defective workplace equipment.
• Is product liability changing in Ireland in 2026? Yes, and the practical effect for consumers is set out in what changes on 9 December 2026.

References

1. Liability for Defective Products Act 1991 (No. 28 of 1991), Irish Statute Book, Office of the Attorney General. Updated April 2024.
2. Making a claim and Annual Report 2024, Injuries Resolution Board. Updated March 2025.
3. Directive (EU) 2024/2853 of the European Parliament and of the Council on liability for defective products, Official Journal of the European Union, 18 November 2024.
4. Personal Injuries Assessment Board Act 2003 (No. 46 of 2003), as amended by the Personal Injuries Resolution Board Act 2022, Irish Statute Book.
5. Product safety alerts and recalls, Competition and Consumer Protection Commission. Updated April 2026.
6. Medical devices safety notices, Health Products Regulatory Authority. Updated April 2026.
7. Personal Injuries Guidelines (1st edition, 2021), Judicial Council of Ireland. Status confirmed May 2026.
8. National Claims Information Database, Central Bank of Ireland. Updated December 2025.
9. Competition and consumer policy: Product Liability Directive transposition update, Department of Enterprise, Tourism and Employment. Updated February 2026.
10. Injuries Resolution Board overview, Citizens Information. Updated January 2026.
11. Report on Multi-Party Litigation (LRC 76-2005), Law Reform Commission of Ireland. Background reading on concurrent wrongdoer mechanics under the Civil Liability Act 1961.
12. Judicial Council Act 2019 (No. 33 of 2019), Irish Statute Book. Section 18 establishes the Personal Injuries Guidelines Committee. Section 7(2)(g) was held unconstitutional in Delaney v Personal Injuries Assessment Board [2024] IESC 10. Status confirmed May 2026.
13. Civil Liability Act 1961 (No. 41 of 1961), Irish Statute Book. Part III governs concurrent wrongdoers. Section 21 governs contribution between concurrent wrongdoers. Referenced by section 8 of the Liability for Defective Products Act 1991.
14. Personal Injuries Resolution Board Act 2022 (No. 42 of 2022), Irish Statute Book. Renamed PIAB to the Injuries Resolution Board with effect from 14 December 2023.
15. Action Plan for Insurance Reform 2025-2029, Department of Finance. Published July 2025. Commits to Judicial Council (Amendment) Bill 2026 in Q1 2026 (currently in pre-legislative scrutiny).